Logo: to the web site of Uppsala University

uu.sePublications from Uppsala University
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Unravelling differences and hallmarks in suspected diffuse low-grade gliomas: a multicentre database study
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Neurosurgery.ORCID iD: 0000-0002-4702-526X
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Surgical Sciences, Molecular imaging and medical physics.ORCID iD: 0000-0002-2502-6026
Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, S-40530 Gothenburg, Sweden..
Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, S-40530 Gothenburg, Sweden.;Univ Gothenburg, Sahlgrenska Acad, Inst Hlth & Care Sci, S-40530 Gothenburg, Sweden..
Show others and affiliations
2025 (English)In: Brain Communications, E-ISSN 2632-1297, Vol. 7, no 5, article id fcaf368Article in journal (Refereed) Published
Abstract [en]

The natural history of suspected diffuse low-grade gliomas (DLGG) depends heavily upon the molecular status. To fully comprehend this integrated information preoperatively, a clinical phenotype incorporating both clinical and radiological information may be of value. We aimed to analyse this systematically in a large multicentre study to identify clinical/radiological phenotypes of DLGG molecular subgroups at the onset. Patients from nine Scandinavian centres, with confirmed World Health Organization (WHO) grade 2 at the time of diagnosis (according to the WHO 2016/2007 classification), known molecular status [isocitrate dehydrogenase (IDH) status and 1p19q codeletion status] and preoperative images of adequate quality, were analysed. MRI-based tumour volume segmentation was used to create a frequency map of their locations in the Montreal Neurological Institute space. A Brain-Grid (BG) system was also used for tumour invasiveness analysis. Variables were analysed for each subgroup of DLGG with regression analyses. A total of 235 patients were included in the study. The three molecular subgroups differed in age, tumour location, epileptic onset and cognitive status. Seizure onset was linked to the number of BG voxels and the A3C2S2 location in all three molecular subgroups. Cognitive deficits were related to increasing age (IDH-mutated oligodendrogliomas), female gender (IDH-wildtype) and tumour volume (oligodendrogliomas). Patients with IDH-mutated astrocytomas (n = 65) displayed younger age, left-sided fronto-insular preferential location, infiltration of anterior ventral inferior fronto-occipital fasciculus (IFOF) and external capsule, and seizure as the onset symptoms. Oligodendrogliomas (n = 116) were more often found in patients >40 years old, with frontal location, dorsal IFOF, frontal aslant tract and superior longitudinal fasciculus invasion, and seizures as the onset symptoms. IDH-wildtype astrocytomas (n = 54) displayed: age >40 years old, left-sided temporo-insular preferential location, invasion of posterior IFOF and cortico-spinal tract, cognitive deficits at onset and the infiltration of posterior left peri-insular voxel (A3C2S3) as a strong predictor of IDH-wildtype. Using an integrated clinico-radiological approach, we identified differences in age, clinical presentation, preferential location and white matter infiltration among specific molecular subgroups of suspected DLGG. The systematic combination of patient-specific variables (age/clinical onset) and tumour-specific features (sub-lobar preferential location) may be relevant to create future prediction models and to better understand the onco-functional trajectory already at the preoperative stage. Prediction models may benefit from combining information rather than, for instance, analysing images only.

Place, publisher, year, edition, pages
Oxford University Press, 2025. Vol. 7, no 5, article id fcaf368
Keywords [en]
diffuse low-grade gliomas, white matter, molecular profile, epilepsy, onco-functional trajectory
National Category
Neurology Cancer and Oncology Neurosciences
Identifiers
URN: urn:nbn:se:uu:diva-577898DOI: 10.1093/braincomms/fcaf368ISI: 001590666200001PubMedID: 41079754Scopus ID: 2-s2.0-105018218556OAI: oai:DiVA.org:uu-577898DiVA, id: diva2:2033396
Available from: 2026-01-29 Created: 2026-01-29 Last updated: 2026-01-29Bibliographically approved

Open Access in DiVA

fulltext(12343 kB)19 downloads
File information
File name FULLTEXT01.pdfFile size 12343 kBChecksum SHA-512
699cd2b622000d26f4e5501c907ee93e10494578feee3decad9b92a3b517490c96d0714717e6fe7c9ae88fd073b52958043d69c9ea870eecab5b29f405426b15
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMedScopus

Authority records

Latini, FrancescoFahlström, MarkusZetterling, Maria

Search in DiVA

By author/editor
Latini, FrancescoFahlström, MarkusZetterling, Maria
By organisation
NeurosurgeryMolecular imaging and medical physics
In the same journal
Brain Communications
NeurologyCancer and OncologyNeurosciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 931 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf